Clinical Trials Logo

Filter by:
NCT ID: NCT01081834 Completed - Clinical trials for Diabetes Mellitus, Type 2

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Start date: March 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy, safety, and tolerability of 2 different doses of canagliflozin administered as monotherapy compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise.

NCT ID: NCT01080209 Completed - Clinical trials for Patients Who Participated in an Intravitreal Brimo PS DDS® Study

Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System

Start date: February 2010
Phase: Phase 2
Study type: Interventional

This study will evaluate the biodegradation of the brimonidine tartrate posterior segment drug delivery system.

NCT ID: NCT01077154 Terminated - Breast Cancer Clinical Trials

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

Start date: June 2, 2010
Phase: Phase 3
Study type: Interventional

This randomized phase 3 trial is studying the effect of denosumab to see if it can prevent disease recurrence in the bone or in any other part of the body, when it is given as adjuvant therapy for women with early-stage breast cancer, who are at high risk of disease recurrence.

NCT ID: NCT01076582 Completed - Oral Contraceptive Clinical Trials

Comparative Trial in Hormone Withdrawal Associated Symptoms

Start date: April 2010
Phase: Phase 3
Study type: Interventional

This clinical research study will examine whether an oral contraceptive pill taken with a monthly hormone-free interval of 4 days reduces hormone withdrawal associated symptoms compared to an oral contraceptive pill taken with a monthly hormone-free interval of 7 days after 4 cycles of treatment.

NCT ID: NCT01076478 Completed - Polyneuropathy Clinical Trials

Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines

ASCEND
Start date: March 2004
Phase: Phase 4
Study type: Interventional

To describe if there are differences in the subjective, objective and electrophysiologic parameters of diabetic polyneuropathies at baseline, four (4) weeks, eight (8) weeks, and twelve (12) weeks after Cilostazol therapy.

NCT ID: NCT01073865 Completed - Breast Cancer Clinical Trials

Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer

Start date: February 26, 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the efficacy and safety as well as the characteristics of the female hormone and study medications after administration in pre-menopausal women with estrogen receptor positive advanced breast cancer who were randomised in a 1:1 ratio to either of the two treatment groups; the ZD9393 3.6 mg depot group or ZD9393 10.8 mg depot group, both given in combination with tamoxifen tablets.

NCT ID: NCT01073644 Terminated - Clinical trials for Metastatic Renal Cell Carcinoma

Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients

Start date: February 2010
Phase: Phase 4
Study type: Observational

The primary purpose is to monitor the safety and tolerability and effectiveness of sunitinib malate in the treatment of patients with metastatic renal cell carcinoma and gastrointestinal stromal tumor among filipino patients in usual clinical practice setting.

NCT ID: NCT01073033 Completed - Diarrhea Clinical Trials

Oral Supplement for Pregnant and Lactating Mothers

Start date: April 2010
Phase: N/A
Study type: Interventional

To assess protection against early life infections through supplementation of mothers during pregnancy to the newborns' growth, morbidity, immune status intra and extra-uterine.

NCT ID: NCT01071850 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus

Start date: March 3, 2010
Phase: Phase 2
Study type: Interventional

Evaluate the efficacy, safety, and tolerability of multiple doses of ASP1941 compared to placebo over 12 weeks of therapy in adult patients with type 2 diabetes mellitus.

NCT ID: NCT01069289 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients

SUMIRE
Start date: January 2010
Phase: Phase 3
Study type: Interventional

The primary purpose of the study is to investigate if Symbicort is more effective than Oxis in increasing forced expiratory volume in one second (FEV1), measured at the clinics, in patients with COPD.